Abstract
The brain’s default mode network (DMN) plays a role in social cognition, with altered DMN function being associated with social impairments across various neuropsychiatric disorders. In the present study, we examined the genetic relationship between sociability and DMN-related resting-state functional magnetic resonance imaging (rs-fMRI) traits.
To this end, we used genome-wide association summary statistics for sociability and 31 activity and 64 connectivity DMN-related rs-fMRI traits (N=34,691-342,461). First, we examined global and local genetic correlations between sociability and the rs-fMRI traits. Second, to assess putatively causal relationships between the traits, we conducted bi-directional Mendelian randomisation (MR) analyses. Finally, we prioritised genes influencing both sociability and rs-fMRI traits by combining three methods: gene-expression eQTL MR analyses, the CELLECT framework using single-nucleus RNA-seq data, and network propagation in the context of a protein-protein interaction network.
Significant local genetic correlations were found between sociability and two rs-fMRI traits, one representing spontaneous activity within the temporal cortex, the other representing connectivity between the frontal/cingulate and angular/temporal cortices. Sociability affected 12 rs-fMRI traits when allowing for weakly correlated genetic instruments. Combing all three methods for gene prioritisation, we defined 17 highly prioritised genes, with DRD2 and LINGO1 showing the most robust evidence across all analyses.
By integrating genetic and transcriptomics data, our gene prioritisation strategy may serve as a blueprint for future studies. The prioritised genes could be explored as potential biomarkers for social dysfunction in the context of neuropsychiatric disorders and as drug target genes.
Highlights
Genetic correlation identified between sociability and temporal cortex activity.
Genetic correlation between sociability and frontal-angular/temporal connectivity.
Sociability was causally linked to 12 MRI traits related to the default mode network.
Seventeen prioritised genes were associated with both sociability and DMN traits.
Competing Interest Statement
AS is or has been a consultant/speaker for Abbott, Abbvie, Angelini, AstraZeneca, Clinical Data, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Innovapharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polifarma, Sanofi, Servier and Taliaz. BF discloses having received educational speaking fees and travel support from Medice. CF was a speaker for Janssen. All other authors report no biomedical financial interests or potential conflicts of interest.
Funding Statement
The PRISM2 project (https://prism2-project.eu/en/prism-study/) leading to this application has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement Number 101034377. The work also was supported by funding from the European Community's Horizon 2020 Programme (H2020/2014 – 2020) under grant agreement Number 847879 (PRIME) and the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH124851. This publication reflects only the authors' views, neither IMI JU, EFPIA, the European Commission, nor the National Institutes of Health are liable for any use that may be made of the information contained therein.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We used publicly available summary statistics of genome-wide association studies conducted by external research groups, thus no specific authorisation was required from the local Ethics Committee. No individual genotypic data were used or collected.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript and/or supplementary materials.
